Mdxhealth SA key statistics and ratios
In fiscal 2025, Mdxhealth SA had an operating margin of -13.4% and a current ratio of 1.08. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|
| Gross margin | 0.3% | 43.6% | 47.5% | 51.9% | 62.6% | 61.2% | 64.5% |
| Operating margin | −366.3% | −146.9% | −120.7% | −102.3% | −38.9% | −27.5% | −13.4% |
| Net margin | −365.7% | −155.3% | −130.4% | −118.9% | −61.4% | −42.3% | −31.1% |
| Free-cash-flow margin | −189.7% | −112.6% | −105.4% | −99.6% | −34.5% | −21.9% | −3.1% |
| Return on equity | — | — | −110.0% | −156.7% | — | — | — |
| Return on assets | — | −90.0% | −54.2% | −45.4% | −34.7% | −26.6% | −22.0% |
| Asset turnover | — | 0.58 | 0.42 | 0.38 | 0.57 | 0.63 | 0.71 |
| Current ratio | — | 1.77 | 4.05 | 1.59 | 1.95 | 1.57 | 1.08 |
| Debt to equity | — | 48.2% | 9.5% | 374.8% | 502.3% | 345.6% | — |
| Interest cover (operating income ÷ interest) | n/m | n/m | n/m | n/m | n/m | n/m | n/m |
| R&D as % of revenue | 76.3% | 24.6% | 25.1% | 14.8% | 9.1% | 11.7% | 9.6% |
| Capital spending as % of revenue | 0.6% | 2.9% | 4.0% | 7.5% | 3.9% | 1.3% | 1.1% |
Financial health
- Short-term assets cover short-term liabilities $53m of assets due within a year against $50m of liabilities due within a year.
- Short-term assets cover long-term liabilities $53m short-term assets against $111m of longer-dated liabilities.
- More cash than debt $29m of cash against $76m of debt.
- Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt −$2m of operating cash flow against $76m of debt.
- Operating profit covers interest at least five times over Operating income of −$14m against $786,000 of interest.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Compare with peers
- Biodesix Inc statistics
- Harvard Bioscience Inc statistics
- Codexis, Inc. statistics
- Quanterix Corp statistics
- Burning Rock Biotech Ltd statistics
Head to head: BDSX vs MDXHHBIO vs MDXHCDXS vs MDXH
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies